Blindness is the most feared human disability. Corneal diseases are one of the most relevant blindness reasons and can be solved only through surgical intervention: any year about 185,00 corneas are transplanted in 116 countries. About 7,500 corneal transplants each year are “doomed to fail”. 12.7 million people are awaiting for transplantation.
STATE OF THE ART
Surgical techniques applied as alternative to transplant, up today, are:
Cataract surgery for lens disease
Artificial retina for retinal disease:
Artificial retina: electrical nerve stimulation of retinal cells
> 20 years in development
> 100 million $ in funding
Only 350 devices implanted
The main problems associated with traditional corneal transplantation are related to immune reactions of rejection, endothelial decay, infection or others similar problems. The innovative solution we propose, as a result of the application of lateral thinking supported by scientific progress and our new findings, is the development and use of an hybrid intracorneal device.
Our hybrid intracorneal device is
EXTRA OCULAR safe implantation
STABLE for storage > 6 month
TRANSPARENT for light transmission
ACELLULAR no immune rejection
BIOLOGIC for bio-integration
BARRIER for globe integrity
INDEPENDENT of endothelial function
WORK IN PROGRESS
Birth of Project
Professor Massimo Busin, applying lateral thinking, begins experimentation to invent an effective alternative to critical cases of corneal transplantation, also easily applicable to the generality of surgeries.
Initial R&D Phase
In collaboration with Eliachar Technology, begins applied research for the use of optical lenses and projectors to replace the diseased cornea.
Corneas Transplants per Year
People awaiting for transplantation
Transplants doomed to fail each Year
Potential Patients per Year